Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis

OBJECTIVES: To determine if disease duration and number of prior disease-modifying antirheumatic drugs (DMARDs) affect response to therapy in patients with established rheumatoid arthritis (RA). METHODS: Associations between disease duration or number of prior DMARDs and response to therapy were ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Aletaha, Daniel, Maa, Jen-fue, Chen, Su, Park, Sung-Hwan, Nicholls, Dave, Florentinus, Stefan, Furtner, Daniel, Smolen, Josef S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900248/
https://www.ncbi.nlm.nih.gov/pubmed/31434637
http://dx.doi.org/10.1136/annrheumdis-2018-214918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900248/
https://www.ncbi.nlm.nih.gov/pubmed/31434637
http://dx.doi.org/10.1136/annrheumdis-2018-214918

Ejemplares similares